Collaboration: Do you have a drug discovery concept? Are you a principal investigator affiliated with a European research institute, college or university? Are you excited about partnering with a leading pharmaceutical company to translate your novel science into a new medicine?
GSK – Discovery Fast Track
Tell us about your concept. Our expert panel of judges will evaluate each submission, selecting up to ten winners.
If your concept is chosen, a team of GSK scientists will collaborate with you to screen your target in the same way as we do for internal projects. We will share key results from the screen to provide you with high-quality chemical probes to allow further exploration of the target towards a potential new medicine. In short, you and your concept will be on an accelerated drug discovery path to success.
Discovery Fast Track is sponsored by GlaxoSmithKline through GlaxoSmithKline’s Discovery Partnerships with Academia (DPAc) team in association with the Platform Technology and Science (PTS) team.
The primary criteria used to assess both initial applications and finalist proposals include:
Strength of the therapeutic hypothesis
Degree of originality of the work presented
Level of completeness of the target/screening assay
Potential impact or benefit of the target to medicine (unmet medical need)
Investigator’s and institution’s capabilities to support entry into the Discovery Fast Track Challenge and for joint execution of a DPAc project.
Helpful Tips for Principal Investigators